Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Recurrent or Metastatic Squamous Cell Carcinoma of the Head and Neck”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Looking for participantsNCT07408063
What this trial is testing

A Comprehensive Multiomic Biomarker Evaluation Across Two Single-arm Cohorts to Elucidate Mechanisms of Response and Resistance in Recurrent/Metastatic (R/M) Head and Neck Squamous Cell Carcinoma (HNSCC)

Who this might be right for
Recurrent/Metastatic Head and Neck Squamous Cell Carcinoma
University Health Network, Toronto 30
Testing effectiveness (Phase 2)Ended earlyNCT01488318
What this trial is testing

Cetuximab and Dasatinib in Recurrent Squamous Cell Carcinoma

Who this might be right for
Squamous Cell Carcinoma Of The Head And Neck
Julie E. Bauman, MD, MPH 21
Testing effectiveness (Phase 2)Study completedNCT03083873
What this trial is testing

Study of LN-145/LN-145-S1 Autologous Tumor Infiltrating Lymphocytes in the Treatment of Squamous Cell Carcinoma of the Head & Neck

Who this might be right for
Squamous Cell Carcinoma of the Head and Neck
Iovance Biotherapeutics, Inc. 64
Testing effectiveness (Phase 2)Study completedNCT00114283
What this trial is testing

Lapatinib Ditosylate in Treating Patients With Metastatic or Recurrent Head and Neck Cancer

Who this might be right for
Recurrent Salivary Gland CancerRecurrent Squamous Cell Carcinoma of the HypopharynxRecurrent Squamous Cell Carcinoma of the Larynx+31 more
National Cancer Institute (NCI) 30
Testing effectiveness (Phase 2)UnknownNCT03771820
What this trial is testing

Combination Therapy With NC-6004 and Pembrolizumab in Head and Neck Cancer Subjects Who Have Failed Platinum Regimen

Who this might be right for
SCCHN
NanoCarrier Co., Ltd. 136
Testing effectiveness (Phase 2)Study completedNCT00003443
What this trial is testing

Bryostatin 1 in Treating Patients With Metastatic or Recurrent Head and Neck Cancer

Who this might be right for
Head and Neck Cancer
Memorial Sloan Kettering Cancer Center
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07686588
What this trial is testing

Sacituzumab Tirumotecan Plus Immunotherapy for Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma

Who this might be right for
Recurrent or Metastatic Head and Neck Carcinoma
Biying Chen 20
Not applicableStudy completedNCT00068497
What this trial is testing

Gefitinib in Treating Patients With Metastatic or Unresectable Head and Neck Cancer or Non-Small Cell Lung Cancer

Who this might be right for
Anaplastic Thyroid CancerInsular Thyroid CancerMetastatic Parathyroid Cancer+83 more
National Cancer Institute (NCI) 40
Testing effectiveness (Phase 2)Study completedNCT03993353
What this trial is testing

Tadalafil and Pembrolizumab in Recurrent or Metastatic Head and Neck Cancer

Who this might be right for
Head and Neck CancerHead and Neck Squamous Cell CarcinomaHead and Neck Carcinoma+9 more
University of California, San Diego 7
Testing effectiveness (Phase 2)Study completedNCT01806675
What this trial is testing

18F-FPPRGD2 PET/CT or PET/MRI in Predicting Early Response in Patients With Cancer Receiving Anti-Angiogenesis Therapy

Who this might be right for
Adult Giant Cell GlioblastomaAdult GlioblastomaAdult Gliosarcoma+41 more
Sanjiv Sam Gambhir 25
Testing effectiveness (Phase 2)Study completedNCT03878979
What this trial is testing

Preoperative Immune Checkpoint Inhibitor for Patients With Primary Untreated or Recurrent/Metastatic SCCHN

Who this might be right for
Head and Neck Squamous Cell CarcinomaHead and Neck CancerHead and Neck Cancer Metastatic
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins 26
Testing effectiveness (Phase 2)Looking for participantsNCT06935188
What this trial is testing

Dalpicilib Plus Cetuximab Compared With Cetuximab Alone in HPV-negative, Anti-PD-1-resistant R/M HNSCC

Who this might be right for
Recurrent/Metastatic Head and Neck Squamous Cell Carcinoma
Shanghai Ninth People's Hospital Affiliated to Shanghai Jiao Tong University 98
Testing effectiveness (Phase 2)Looking for participantsNCT07617805
What this trial is testing

EGFR/HER2 Dual-Target CAR-NK Cells for Recurrent or Metastatic HNSCC

Who this might be right for
Recurrent or Metastatic Head and Neck Squamous Cell CarcinomaBiomarker-positive EGFR/HER2- Expressing HNSCC
Beijing Biotech 42
Testing effectiveness (Phase 2)Study completedNCT02538510
What this trial is testing

Pembrolizumab and Vorinostat in Treating Patients With Recurrent Squamous Cell Head and Neck Cancer or Salivary Gland Cancer That Is Metastatic and/or Cannot Be Removed by Surgery

Who this might be right for
Head and Neck Squamous Cell CarcinomaRecurrent Nasal Cavity and Paranasal Sinus Squamous Cell CarcinomaRecurrent Nasopharynx Carcinoma+12 more
University of Washington 50
Large-scale testing (Phase 3)Study completedNCT01345682
What this trial is testing

LUX-Head&Neck 1: A Phase III Trial of Afatinib (BIBW2992) Versus Methotrexate for the Treatment of Recurrent and/or Metastatic (R/M) Head and Neck Squamous Cell Cancer After Platinum Based Chemotherapy

Who this might be right for
Head and Neck NeoplasmsCarcinoma, Squamous Cell
Boehringer Ingelheim 483
Testing effectiveness (Phase 2)Study completedNCT00617734
What this trial is testing

Study of IMC-A12, Alone or in Combination With Cetuximab, in Participants With Recurrent or Metastatic Squamous Cell Carcinoma (MSCC) of the Head and Neck

Who this might be right for
Head and Neck Cancer
Eli Lilly and Company 97
Testing effectiveness (Phase 2)Study completedNCT00824343
What this trial is testing

A Phase II Clinical Trial to Study the Efficacy and Safety of a New Drug P276-00 in Treatment of Recurrent and/or Locally Advanced Head and Neck Cancer

Who this might be right for
Squamous Cell Carcinoma of Head and Neck
Piramal Enterprises Limited 86
Early research (Phase 1)Study completedNCT01254617
What this trial is testing

Lenalidomide and Cetuximab in Treating Patients With Advanced Colorectal Cancer or Head and Neck Cancer

Who this might be right for
Recurrent Colon CarcinomaRecurrent Hypopharyngeal Squamous Cell CarcinomaRecurrent Laryngeal Squamous Cell Carcinoma+39 more
National Cancer Institute (NCI) 24
Early research (Phase 1)Active Not RecruitingNCT03498378
What this trial is testing

Avelumab, Cetuximab, and Palbociclib in Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma

Who this might be right for
Head and Neck Squamous Cell Carcinoma
Kathryn Gold 24
Testing effectiveness (Phase 2)Study completedNCT04811027
What this trial is testing

Combination Study With Eftilagimod Alpha (a Soluble LAG-3 Fusion Protein) and Pembrolizumab in Patients With Recurrent or Metastatic HNSCC

Who this might be right for
HNSCC
Immutep S.A.S. 171
Next Page